Cite
HARVARD Citation
Abu‐Khalaf, M. et al. (2015). Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors. Cancer. 121 (11), pp. 1817-1826. [Online].